Search results for "Virus Disease"

showing 10 items of 1907 documents

Infection with human herpes virus type 8 in an area at high prevalence for hepatitis C virus infection in southern Italy

2004

Summary.  The Campania Region is a geographical area of southern Italy characterized by high incidence rates of hepatocellular carcinoma and of classic Kaposi's sarcoma. Epidemiological investigations carried out among different population groups in this region have found high prevalence rates of both hepatitis C virus (HCV) and human herpesvirus type 8 (HHV-8). To assess co-infection rates of HCV and HHV-8, we carried out a cross-sectional seroepidemiological study prevalence in Pomigliano d'Arco, a Health District of Campania located 20 km away from Naples. The overall rate of HCV/HHV-8 co-infection was 3.1%, 3.5% among men and 2.7% among women. No difference emerged in the HCV/HHV-8 co-i…

AdultMalemedicine.medical_specialtyvirusesHepatitis C virusPopulationAntibodies Viralmedicine.disease_causeSeroepidemiologic StudiesVirologyEpidemiologyHumansMedicineeducationAgededucation.field_of_studyHigh prevalenceHepatologybusiness.industryTransmission (medicine)Human herpes virusPublic healthvirus diseasesHerpesviridae InfectionsHepatitis C AntibodiesMiddle Agedmedicine.diseaseHepatitis CVirologyCross-Sectional StudiesInfectious DiseasesItalyHepatocellular carcinomaHerpesvirus 8 HumanFemalebusinessJournal of Viral Hepatitis
researchProduct

Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy

2011

Abstract Background Hepatitis E virus (HEV) is a major cause of acute hepatitis in developing countries, whereas it is not considered a major health problem in Western World. Aims To investigate the spread of HEV and its possible role in causing acute hepatitis in Southern Italy. Methods Four hundred and thirty patients observed from April to December 2009 were studied and grouped as follows: 55 individuals with acute hepatitis (AH), 33 of whom cryptogenic; 321 individuals with chronic liver diseases (CLD), (278 Italians and 43 immigrants); 54 individuals without liver disease (control-group). Serum samples from all cases were tested for IgG anti-HEV antibodies and those positive to this te…

AdultMalemedicine.medical_specialtyvirusesmedicine.disease_causeZOONOSISHepatitisLiver diseaseCHRONIC LIVER-DISEASEYoung AdultHepatitis E virusEpidemiologymedicineHepatitis E virusHumansAcute hepatitisHepatitis AntibodiesHepatologybiologybusiness.industryLiver DiseasesGastroenterologyvirus diseasesMiddle AgedHepatitis Emedicine.diseaseSerum samplesVirologydigestive system diseasesHepatitis EImmunoglobulin MItalyImmunoglobulin GChronic Diseasebiology.proteinRNA ViralFemaleAntibodycryptogenic Acute HepatitisbusinessHepatitis E virus infectionAcute hepatitisSerological diagnosis Hepatitis E Virus Acute hepatitis ZOONOSIS CHRONIC LIVER-DISEASE cryptogenic Acute HepatitisSerological diagnosis
researchProduct

Increased seroprevalence of parvovirus B 19 IgG in complex regional pain syndrome is not associated with antiendothelial autoimmunity

2005

The etiology of complex regional pain syndrome (CRPS) is unclear yet. Recently autoantibodies and antecedent viral infections have been discussed to be involved in the pathogenesis of CRPS. We investigated sera from 39 CRPS patients and healthy controls for parvovirus B19 IgG and the occurrence of antiendothelial autoantibodies (AECA). CRPS patients showed a higher seroprevalence of parvovirus B19 IgG than controls (p < 0.01). All CRPS 2 patients were positive. 10.2% of the CRPS patients and 10.0% of the controls had AECA (n.s.) and AECA were not associated with parvovirus B19 seropositivity. Our findings suggest the involvement of parvovirus B19, but not autoantibody-mediated endothelial c…

AdultMalevirusesEnzyme-Linked Immunosorbent AssayAntibodies Viralmedicine.disease_causeAutoimmune DiseasesAutoimmunityParvoviridae InfectionsPathogenesisSeroepidemiologic StudiesParvovirus B19 HumanmedicineHumansSeroprevalenceEndotheliumAgedAutoantibodiesbiologybusiness.industryParvovirusAutoantibodyvirus diseasesMiddle Agedbiology.organism_classificationmedicine.diseaseAnesthesiology and Pain MedicineComplex regional pain syndromeImmunoglobulin GImmunologybiology.proteinEtiologyFemaleAntibodybusinessComplex Regional Pain SyndromesEuropean Journal of Pain
researchProduct

Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.

2004

Hepatitis C virus (HCV) variation in specific T-cell epitopes may represent a mechanism of viral persistence in chronic infection. We examined the HCV non-structural protein 3 (NS3), including the immunologically relevant epitopes HCV NS3-2 KLVALGINAV (human leukocyte antigen [HLA]-A2-restricted) and HCV NS3-1391 LIFCHSKKK (HLA-A3-restricted), in 22 HLA-A2+ patients with chronic infection. Significant amino acid variation was found in HCV NS3-2 epitope sequences when compared to the HCV-1 prototype virus. Six of the nine different HCV NS3-2 peptide variants were identified in patients with HCV NS3-2-specific CD8+ cells, detected with an HLA-A2 tetramer made with the HCV-1 prototype peptide.…

AdultMalevirusesHepacivirusHepatitis C virusMolecular Sequence DataEpitopes T-LymphocyteHuman leukocyte antigenHepacivirusCD8-Positive T-LymphocytesHLA-A3 AntigenViral Nonstructural Proteinsmedicine.disease_causeEpitopeVirusFlaviviridaeVirologySequence Homology Nucleic AcidHLA-A2 AntigenmedicineHumansAmino Acid SequencePhylogenyAgedNS3Polymorphism GeneticbiologyGenetic heterogeneityReverse Transcriptase Polymerase Chain Reactionvirus diseasesGenetic VariationHepatitis C ChronicMiddle Agedbiology.organism_classificationVirologydigestive system diseasesInfectious DiseasesImmunologyRNA ViralFemaleHepatitis C AntigensJournal of medical virology
researchProduct

T helper cell-mediated interferon-gamma expression after human parvovirus B19 infection: persisting VP2-specific and transient VP1u-specific activity.

2005

SummaryHuman parvovirus B19 is a small non-enveloped DNA virus with an icosahedral capsid consisting of proteins of only two species, the major protein VP2 and the minor protein VP1. VP2 is contained within VP1, which has an additional unique portion (VP1u) of 227 amino acids. We determined the ability of eukaryotically expressed parvovirus B19 virus-like particles consisting of VP1 and VP2 in the ratio recommended for vaccine use, or of VP2 alone, to stimulate, in an HLA class II restricted manner, peripheral blood mononuclear cells (PBMC) to proliferate and to secrete interferon gamma (IFN-γ) and interleukin (IL)-10 cytokines among recently and remotely B19 infected subjects. PBMC reactiv…

AdultMalevirusesImmunologyPeripheral blood mononuclear cellVirusParvoviridae Infections03 medical and health sciencesEpitopesInterferon-gammaAntigenPregnancymedicineParvovirus B19 HumanImmunology and AllergyHumansInterferon gammaPregnancy Complications InfectiousCells Cultured030304 developmental biologyParvoviridae0303 health sciencesImmunity Cellularbiology030306 microbiologyParvovirusHistocompatibility Antigens Class IIInterleukinvirus diseasesT helper cellT-Lymphocytes Helper-InducerOriginal ArticlesMiddle Agedbiology.organism_classificationVirology3. Good healthInterleukin-10Endotoxinsmedicine.anatomical_structureImmunologyLeukocytes MononuclearCapsid ProteinsFemaleCell Divisionmedicine.drugClinical and experimental immunology
researchProduct

Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults

2021

ABSTRACTObjectivesThere is limited information comparing SARS-CoV-2 RNA load in the upper respiratory tract (URT) between children and adults, either presenting with COVID-19 or asymptomatic. Here we conducted a retrospective, single center study involving a large cohort of SARS-CoV-2 infected individuals to address this issue.Patients and MethodsA total of 1,184 consecutive subjects (256 children and 928 adults) testing positive for SARS-COV-2 RNA in nasopharyngeal exudates (NP) were included, of whom 424 (121 children and 303 adults) had COVID-19 not requiring hospitalization and 760 (135 children and 625 adults) were asymptomatic close contacts of COVID-19 patients. SARS-CoV-2 RNA testin…

AdultMicrobiology (medical)medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PopulationSingle CenterAsymptomaticGastroenterologychildrenNasopharynxInternal medicinemedicineSingle specimenAdultsHumansViral sheddingChildeducationAsymptomatic InfectionsRetrospective Studieseducation.field_of_studySARS-CoV-2business.industryCOVID-19RNAGeneral MedicineViral LoadSARS-CoV-2 RNALarge cohortInfectious Diseasesmedicine.anatomical_structureRNA ViralOriginal Articlemedicine.symptombusinessViral loadUpper respiratory tractRespiratory tractClinical Microbiology and Infection
researchProduct

Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine administered according to an alternative dosing schedule compared wit…

2011

BACKGROUND: The human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine is immunogenic, has a clinically acceptable safety profile, and prevents incident and persistent HPV-16/18 infection and cervical precancerous lesions. This study (NCT00552279) evaluated the vaccine when administered according to an alternative dosing schedule (0-1-12 months) compared with the standard dosing schedule (0-1-6 months). METHODS: The study was of randomized open design and was conducted at multiple centers in Europe. Healthy women aged 15 to 25 years were randomized (1:1) to receive HPV-16/18 vaccine according to the standard schedule at months 0, 1, and 6 (n = 401) or an alternative schedule at months 0, …

AdultMicrobiology (medical)medicine.medical_specialtyScheduleAdolescentImmunization SecondaryEnzyme-Linked Immunosorbent AssayAntibodies Virallaw.inventionYoung AdultAdjuvants ImmunologicRandomized controlled triallawInternal medicinemedicineHumansPapillomavirus VaccinesDosingHuman papillomavirusYoung adultbusiness.industryImmunogenicityhuman papillomavirus human papillomavirus vaccines adolescent immunology alternative dosing scheduleVaccinationvirus diseasesSettore MED/40 - Ginecologia E Ostetriciafemale genital diseases and pregnancy complicationsEuropeSafety profileInfectious DiseasesImmunizationPediatrics Perinatology and Child HealthImmunologyFemalebusiness
researchProduct

Transfer of aciclovir from plasma to human breast milk.

2011

Aciclovir (CAS 59277-89-3) is frequently used in herpes simplex virus diseases, but administration to lactating women occurs only rarely. Therefore, information about the pharmacokinetics of aciclovir in human breast milk is limited. The concentration in breast milk is 2 to 3 fold increased compared to plasma. The reason for this increase is unknown until now. An active transport mechanism has been assumed. The aim of this study was to prove whether the higher concentration of aciclovir in human breast milk is due to only a passive transfer. Two chambers separated by a semipermeable membrane were used. The first chamber contained plasma with aciclovir, the second chamber breast milk without…

AdultMilk HumanChemistryAcyclic nucleosidevirus diseasesHuman metabolismAcyclovirPharmacologyBreast milkmedicine.disease_causeAntiviral AgentsDiffusionHerpes simplex virusPharmacokineticsDrug DiscoveryBlood plasmaImmunologymedicineHumansFemaleAciclovirHuman breast milkmedicine.drugArzneimittel-Forschung
researchProduct

Human papillomavirus antibody responses among patients with incident cervical carcinoma

1997

The human papillomavirus (HPV) is recognized as a major cause of cervical cancer precursor lesions. HPV serology is a key method in the continuing elucidation of the importance of HPV exposure for cancer development and in predicting HPV-associated diseases. To extend previous HPV serological studies on cervical cancer, serum samples from a consecutive series of 216 women with incident untreated cervical carcinoma and 243 age- and sex-matched healthy blood donors were evaluated for the presence of antibodies against HPV capsids, a marker of past or present HPV exposure, as well as against several cervical cancer-associated defined HPV epitopes. Among the capsid antibody responses, HPV type …

AdultMolecular Sequence DataUterine Cervical NeoplasmsAntibodies ViralKlinikai orvostudományokEpitopeSerologyEpitopesCapsidRisk FactorsVirologyCarcinomamedicineHumansAmino Acid SequenceRisk factorAntigens ViralPapillomaviridaeAgedAged 80 and overCervical cancerbiologybusiness.industryPapillomavirus Infectionsvirus diseasesOrvostudományokMiddle Agedmedicine.diseaseVirologyfemale genital diseases and pregnancy complicationsTumor Virus InfectionsInfectious DiseasesCase-Control StudiesImmunologybiology.proteinFemaleHuman Papillomavirus AntibodyViral diseaseAntibodybusiness
researchProduct

Hemichorea associated with varicella-zoster reinfection and endocarditis. A case report.

1985

A 20-year-old woman developed transient right-sided hemichoreatic movements after household exposure to varicella-zoster. Some days before the appearance of involuntary movements a vesicular rash had occurred. About 6 months later an elevated IgG serum titer against varicella virus was found and two-dimensional echocardiography showed signs of an endocarditis. During the following 2 months the IgG value returned to within the normal range and the choreatic movements disappeared almost totally. The possibility is discussed that endocarditis had been caused and maintained by serum antibodies to varicella-zoster virus which cross-reacted with valvular tissue. Embolization to the region of the …

AdultMyoclonusmedicine.medical_specialtyHerpesvirus 3 HumanHeart diseasevirusesmedicine.medical_treatmentAntibodies ViralGastroenterologyHerpes ZosterVirusFunctional LateralityChoreaInternal medicinemedicineEndocarditisHumansPharmacology (medical)EmbolizationAthetosisBiological PsychiatryEndocarditisbusiness.industryGeneral Neurosciencevirus diseasesChoreaGeneral Medicinemedicine.diseaseSurgeryPsychiatry and Mental healthTiterNeuropsychology and Physiological PsychologyEchocardiographyImmunoglobulin GFemaleViral diseasemedicine.symptombusinessEncephalitisEuropean archives of psychiatry and neurological sciences
researchProduct